MDS Plans Shareholder Meeting for Danaher Deal | GenomeWeb

NEW YORK (GenomeWeb News) – MDS has called a meeting to win the nod of its shareholders for the sale of its MDS Analytical Technologies business to Danaher for $650 million, MDS said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.